Launch and Commercialisation

Taking the pain out of outsourcing to maximise commercial success and market impact

We take the pain out of outsourcing and help you from strategic consultancy to high quality delivery. Leverage our deep understanding of launch and commercialisation projects and our reputation for quality delivery to maximise commercial success and market impact for bio-pharma products.

Pharmaceutical and biotech companies are facing increasing market pressure to get new products to market faster than ever. Even after achieving regulatory approval, there are no guarantees of patient access and commercial success. In fact, streamlined regulatory data packages may even make it harder to ensure all patients can benefit from a new therapy.

Strategically focused for commercial success and market adoption

We here at Veramed understand that both ‘Launch’ and ‘Commercialisation’ bring their own challenges and strategic needs. We will support you with a range of strategically-focused and collaborative services that help maximise launch impact and commercial success. Whether you want to get strategic advice years before launch or execute specific tactics like publications, we help you meet your goals and strategic needs all the way through to long-term patient or end-buyer adoption.

We will help your team avoid the common pitfalls, safeguarding you from mistakes many bio-pharma companies make during product launch and commercialisation. Discover more about our process below.

What we can provide

We provide a range of services to ensure that you meet your strategic objectives and achieve commercial success.

Real World Evidence

We develop high-quality observational studies – both prospective and retrospective – to complement clinical trials with real-world data. Our expertise in both pre-launch and post-launch observational research will serve your evidence needs across patients, physicians and payers.

Strategic Evidence Planning

Leverage our expertise across different companies and therapeutic areas to provide outstanding advice about when you want to communicate certain evidence, in a certain format and to which customers so you can optimally plan your data generation solutions accordingly. Our team helps you to identify and fill strategic evidence gaps, and optimise the communication of the benefits and risks of a new therapy.

We partner with you to develop a keen understanding of how your new therapy fits into the existing medical landscape based on your company’s internal and competitive intelligence data. This is an in-depth, collaborative process that considers the needs of patients, physicians, and payers.

Publication planning

Based on the strategic pillars of your compound, we develop and execute publication plans with you, customised to your processes. Based on our experience with hundreds of publications across various therapeutic areas, we not only help you to write the publications, we also suggest additional publication ideas to optimise the communication around your asset.

We align these suggestions with the compound specific strategic needs of your product. We provide high-quality data visualizations to engage audiences and communicate key take-aways effectively.

Data Mining

Our data mining and network meta-analysis services maximise the value of existing internal or external data. Leverage your existing data to maximize the value for a sponsor’s internal understanding of the data and communications to patients, physicians, and payers. We provide customised solutions to understand your data. Instead of screening through hundreds of static tables, explore your data easily and find key findings via interactive visual tools.

HTA submission

Maximise the opportunity of successful HTA submissions. Our experience with HTA submissions on a global scale will help you to prepare HTA dossiers efficiently and to the highest quality. We help you leverage internal and external data to get the key messages across to payers and explain these in payer facing interactions like the German GBA hearing.

HTA submissions – especially in Germany and the UK – require knowledge of the processes, excellent communication skills in local language, and flexible high-quality deliverables. Our unique insights and experience allow us to create customised local language deliverables efficiently and of the highest quality.

Customer interactions

Ensure high quality interactions with all your external customers including key opinion leaders (KOLs), practicing physicians, key accounts, and patients. We attend or help you attend advisory boards with KOLs to optimise the understanding and communication of data. We train your internal customer facing teams (medical scientific liasons and other) to communicate data with quality. 

From inception to market success

Maximising launch impact

At launch, there is only one chance to get it right and many obstacles to derail success.

Our experience in successfully launching products on both a global and local level means we’re able to address any pitfalls or challenges your team is facing long before going to market through close collaboration and strategic evidence planning. Our approach includes evaluating additional sources of evidence from clinical trials, real-world evidence, data mining/network meta-analysis and more.

Once launched, we help develop an optimal communication stream of your data to patients, payers, and physicians, which can then be better shared with your company internally.

We collaborate not only with the traditional internal stakeholders of statistics and data science – medical and pricing, re-reimbursement, and access – but also with marketing, medical information/education and sales.

Upcoming webinar

9 strategic insights you get from a great medical affairs statistician


What’s your experience of working with Statisticians in medical affairs?
Do they only deliver the tables you asked for?
Do they share why they can’t deliver what you asked for?
Do you struggle to receive the analyses you need in time?

In our latest webinar, Alexander Schacht, EVP of Launch and Commercialization Data Sciences at Vermed, discusses the integral role Statisticians have in helping build a world class medical affairs team.

Alexander will reflect on his 20 years of experience working in medical affairs, and use first-hand case studies to provide 9 strategic insights you can garner from a great medical affairs Statistician.

Webinar Catch-up

Our latest webinar, ‘9 strategic insights you get from a great medical affairs statistician’ is now available.

To view all previous webinar recordings, simply click here.

Data driven

Our vision is to provide company internal and external stakeholders with the right data at the right time to make the right decisions. This ranges from understanding the clinical and real-world data to building a strategic evidence plan and data mining of your internal data sources.

Passion and Expertise

As a people-focused CRO, we’re passionate about delivering high-quality, on time deliverables that ensure new remedies get to the market faster. Our expert team brings years of experience and that ‘Veramed touch’ to the table, focusing on close collaboration and effective planning to help you through launch and commercialisation.

Comprehensive support

We provide the right support, built and delivered through a collaborative, trusting relationship. This close collaboration help create an effective launch strategy on time, as well as commercialisation plan that maximises ROI and market traction.

Get in touch


Have you found what you are looking for? Learn more about our other services below or get in touch.

Statistical Consultancy

We provide a comprehensive statistical service, from study design through to submission and beyond.

Data Monitoring Committees (DMC)

We provide a wide variety of DMC offerings, from one-off consultation to full end-to-end Statistical Data Analysis Centre with administrative and logistical support.

Functional Service Provider

Our bespoke FSP relationships allow us to partner with you to understand your requirements, build trust, enhance quality and develop long-term, collaborative relationships.

Study Reporting & Analysis

We offer a range of outsourced and insourced Study Reporting & Analysis services.

Biotech Due Diligence

A Veramed & Weatherden partnership, we offer data driven due diligence of your assets to help you better seek potential acquirees or partners.


Our Automation, Efficiency and Standards group helps you to assess, evaluate and implement enhancements to your clinical trial workflows.

The team are competent statisticians and programmers, but also personable and friendly and very easy to work with. We have full and frank communication, we work as closely with them as if they were internal staff.

FSP client since 2017

Many thanks to all of you for your hard work on these outputs. I don’t think I’ve ever done QC with so few comments. It's been a pleasure to work with your excellent team.

Client since 2015

I am very impressed at your professionalism and very grateful for your careful and effective management of this significant project issue. Many thanks for your hard work.

FSP client since 2018

I knew you guys were good. That’s perfect. Not every vendor is. The SAP and shells were in very good shape if those are my only 3 comments about those two documents. You did a wonderful job.

FSP client since 2018

Functional Service Provider

Statistical Consultancy

Biotech Due Diligence

Data Monitoring Committees (DMC)

Study Reporting & Analysis